Company / Cash per Share
AIM ImmunoTech Inc. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$4.56
FY2025
5-year range
$0.03 / $4.56
FY2021-FY2025
Trend
+13050.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share changed +13050% YoY in FY2025, a notable deviation from the 9-year average annual change of +3041%.
Based on SEC 10-K filings.
4.56 in FY2025 with a 5-year CAGR of +4.2%.
Improved from $0.11 to $4.56 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +100.7%
- 5-Year CAGR
- +4.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, cash per share increased 13050.1% year-over-year.
- Lowest cash per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -71.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.56 | +13050.1% |
| FY2024 | $0.03 | -69.4% |
| FY2023 | $0.11 | -79.9% |
| FY2022 | $0.56 | -26.0% |
| FY2021 | $0.76 | -79.5% |
| FY2020 | $3.71 | +179.3% |
| FY2019 | $1.33 | +14496.7% |
| FY2018 | $0.01 | -90.9% |
| FY2017 | $0.10 | -14.8% |
| FY2016 | $0.12 | +1025.9% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026